The anticancer effect of Sirt6 was influenced by upregulation of ROS, as Sirt6 overexpression significantly increased ROS expression, whereas NAC (a scavenger for ROS) decreased the apoptotic activity of Sirt6 in HNSCC cells. Here, SIRT6 is linked to head and neck squamous cell carcinoma.